Severe Hypercapnia Requiring 48-h Whole-Body Hypothermia in an Infant with Acute Bronchiolitis

• Published in: Children (Basel) Vol. 9; no. 9; p. 1339
• Main Authors: Librandi, Michela, Scapaticci, Serena, Chiavaroli, Valentina, Petrucci, Altea, Cicioni, Paola, Cognigni, Rita, Chiarelli, Francesco, Di Valerio, Susanna
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.09.2022; MDPI
• Subjects: Antibiotics; Babies; Body temperature; Brain damage; Bronchiolitis; Carbon dioxide; Cardiovascular system; Care and treatment; Case Report; Childrens health; Coronaviruses; COVID-19; Disease prevention; Hospitalization; hypercapnia; Hypothermia; Hypoxia; infant; Infants (Newborn); Influenza; Intensive care; Lungs; Metabolism; Newborn babies; Patients; Physiological aspects; Respiratory distress syndrome; Respiratory failure; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Surfactants; Ventilators; United States
• ISSN: 2227-9067; 2227-9067
• DOI: 10.3390/children9091339

Bronchiolitis is a clinical syndrome involving the lower respiratory tract of infants and young children. The majority of patients recover using adequate hydration and oxygen (O2) therapy, while a small number of patients require ventilatory assistance. Beyond these therapeutical approaches, there are no available strategies for patients that do not improve. Hypothermia is a measure used to prevent neonatal hypoxic–ischemic encephalopathy by preventing carbon dioxide (CO2) production and subsequent tissue damage. Other medical applications of hypothermia have been proposed, such as in acute respiratory failure and necrotizing colitis. Case report: We report the case of a 50-day-old girl hospitalized with severe bronchiolitis caused by respiratory syncytial virus. On admission, the girl presented severe hypercapnic respiratory failure, requiring intubation and ventilatory support with conventional and non-conventional systems. However, the patient’s general conditions worsened with elevated O2 demand, thus whole-body hypothermia was attempted and performed for 48 h, with a gradual improvement in the respiratory function. No adverse effects were detected. Conclusions: Whole-body hypothermia could have a critical role as a rescue treatment in infants affected by severe hypercapnic respiratory failure, at the expense of few and rare side effects (bradycardia, coagulopathy, hyperglycemia). Notably, beyond reducing CO2 production, whole-body hypothermia might have an impact in restoring lung function in newborns using bronchiolitis refractory to maximal medical therapy and invasive ventilation.